Ora Biomedical accelerates the development of longevity therapies through high-throughput live animal screening and machine learning. Their WormBot-AI platform automates drug screening in live animals, enabling the discovery of therapeutic candidates that traditional methods may overlook. The company focuses on bridging fundamental science with translational breakthroughs in drug development.
Analyze movement and behavior in C. elegans models; Track therapeutic impacts in real-time; Discover interventions that restore mobility; Extend healthspan in aging models; Conduct high-throughput screening at unprecedented scale
12101 Tukwila International BLVD Suite 210, Tukwila, Washington 98168, United States